Oxcarbazepine Tablet, Extended Release
Product Images NDC 27241-239

This text appears to be information about a medication. It includes details on the dosage of each extended-release tablet containing 150 mg of Oxcarbazepine, USP. It advises to store the medication at a temperature range of 20°C to 25°C and protect it from light and moisture. The package is child-resistant, and the medication should be dispensed as a whole tablet without cutting, crushing, or chewing. Additionally, it mentions that the medication should be kept out of reach of children and includes instructions for pharmacists to dispense the Accompanying Medication Guide to each patient.*

The text provides information on an extended-release tablet containing 300 mg of 5-Oxcarbazepine, USP. It suggests referring to the package insert for dosage details and other prescribing information. The package is child-resistant, and storage instructions include keeping it at a temperature range of 20°C to 25°C (68°F to 77°F) with limitations on excursions. It advises against cutting, crushing, or chewing the tablet and mentions protection from light and moisture. The code on the package is GUJ/DRUGS/G/25/2080, and it is recommended to dispense in a light-resistant container, keeping it out of reach of children. Additionally, there is a note for pharmacists to dispense an accompanying Medication Guide to each patient.*

This text provides information about Oxcarbazepine extended-release tablets containing 600 mg. It includes storage instructions, dosage details, and the manufacturer's data (Ajanta Pharma USA Inc.). The tablets are child-resistant and should be stored at room temperature, protected from light and moisture. It also emphasizes that the tablets should be swallowed whole and not cut, crushed, or chewed. Pharmacies are advised to dispense the medication guide along with the tablets to each patient.*